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Background: It is established that an elevated cardiac troponin (TN) level is associated with hemodynamically significant pulmonary embolism 
(PE) and poor outcome. However, the management implications of undetectable TN with ultrasensitive assays have not been evaluated. We 
hypothesized that a negative ultrasensitive TN assay is associated with very low in-hospital adverse events.
methods: We conducted a retrospective cohort study of consecutive patients diagnosed with PE in the period from 2008 to 2012, confirmed 
by pulmonary CT angiography or VQ scan. We tabulated the first TN I level within 24 hours from PE diagnosis (Ortho VITROS®). We determined 
prespecified in-hospital outcome events of death, cardiopulmonary resuscitation, thrombolytic therapy, ICU admission, and inferior vena cava filter 
placement. The well validated PE Severity Index (PESI) was calculated.
Results: We identified 398 patients with confirmed PE, of whom 336 (84%) had a qualifying TN assay on record. Among the 162 (48%) patients 
with undetectable TN (≤ 12 pg/ml), none (0%) had the primary outcome of in-hospital death vs. 10 (6%) among those with elevated TN (P = 0.002). 
The secondary outcome of in-hospital death, resuscitation or lytic therapy was observed in 16 (9%) of TN positive patients vs. none (0%) of TN 
negative patients. The secondary outcome of ICU admission or inferior vena cava filter placement was observed in 69 (40%) of TN positive patients 
vs. 21 (13%) of TN negative patients (P < 0.001). Multivariate logistic regression analysis demonstrated that a negative TN is “protective” of in-
hospital events [OR = 0.26 (95% CI = 0.15 - 0.45), P < 0.001], after adjusting for the PE Severity Index, which in turn was independently predictive 
of adverse outcome (P = 0.001).
conclusions:Negative ultrasensitive TN I assay is an excellent prognostic indicator in patients with acute PE. This study suggests that patients with 
undetectable TN using ultrasensitive assays may be discharged from the emergency room after a short observation. This would impact nearly one half 
of patients with acute PE, greatly reducing cost. If validated, our findings may create a paradigm shift in the management of acute PE.
